CAY10603, through its selective inhibition of AChE and subsequent elevation of acetylcholine levels, activates surface receptors on cholangiocarcinoma cells, inducing apoptosis in tumor cells (Khorsandi et al., 2021). This evidence concerns the gene ACHE and cholangiocarcinoma.